Global Newcastle Disease Vaccine Market Insights and Forecast to 2028

Report ID: 1200640 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Newcastle Disease Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Live Vaccines
        1.2.3 Killed Vaccines
    1.3 Market by Application
        1.3.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Chicken
        1.3.3 Duck & Goose
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Newcastle Disease Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Newcastle Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Newcastle Disease Vaccine Sales by Region
        2.4.1 Global Newcastle Disease Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Newcastle Disease Vaccine by Region (2023-2028)
    2.5 Global Newcastle Disease Vaccine Revenue by Region
        2.5.1 Global Newcastle Disease Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Newcastle Disease Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Newcastle Disease Vaccine Sales by Manufacturers
        3.1.1 Global Top Newcastle Disease Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Newcastle Disease Vaccine in 2021
    3.2 Global Newcastle Disease Vaccine Revenue by Manufacturers
        3.2.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Newcastle Disease Vaccine Revenue in 2021
    3.3 Global Newcastle Disease Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Newcastle Disease Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Newcastle Disease Vaccine Sales by Type
        4.1.1 Global Newcastle Disease Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Newcastle Disease Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Newcastle Disease Vaccine Revenue by Type
        4.2.1 Global Newcastle Disease Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Newcastle Disease Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Newcastle Disease Vaccine Price by Type
        4.3.1 Global Newcastle Disease Vaccine Price by Type (2017-2022)
        4.3.2 Global Newcastle Disease Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Newcastle Disease Vaccine Sales by Application
        5.1.1 Global Newcastle Disease Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Newcastle Disease Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Newcastle Disease Vaccine Revenue by Application
        5.2.1 Global Newcastle Disease Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Newcastle Disease Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Newcastle Disease Vaccine Price by Application
        5.3.1 Global Newcastle Disease Vaccine Price by Application (2017-2022)
        5.3.2 Global Newcastle Disease Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Newcastle Disease Vaccine Market Size by Type
        6.1.1 North America Newcastle Disease Vaccine Sales by Type (2017-2028)
        6.1.2 North America Newcastle Disease Vaccine Revenue by Type (2017-2028)
    6.2 North America Newcastle Disease Vaccine Market Size by Application
        6.2.1 North America Newcastle Disease Vaccine Sales by Application (2017-2028)
        6.2.2 North America Newcastle Disease Vaccine Revenue by Application (2017-2028)
    6.3 North America Newcastle Disease Vaccine Market Size by Country
        6.3.1 North America Newcastle Disease Vaccine Sales by Country (2017-2028)
        6.3.2 North America Newcastle Disease Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Newcastle Disease Vaccine Market Size by Type
        7.1.1 Europe Newcastle Disease Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Newcastle Disease Vaccine Revenue by Type (2017-2028)
    7.2 Europe Newcastle Disease Vaccine Market Size by Application
        7.2.1 Europe Newcastle Disease Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Newcastle Disease Vaccine Revenue by Application (2017-2028)
    7.3 Europe Newcastle Disease Vaccine Market Size by Country
        7.3.1 Europe Newcastle Disease Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Newcastle Disease Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Newcastle Disease Vaccine Market Size by Type
        8.1.1 Asia Pacific Newcastle Disease Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Newcastle Disease Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Newcastle Disease Vaccine Market Size by Application
        8.2.1 Asia Pacific Newcastle Disease Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Newcastle Disease Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Newcastle Disease Vaccine Market Size by Region
        8.3.1 Asia Pacific Newcastle Disease Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Newcastle Disease Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Newcastle Disease Vaccine Market Size by Type
        9.1.1 Latin America Newcastle Disease Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Newcastle Disease Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Newcastle Disease Vaccine Market Size by Application
        9.2.1 Latin America Newcastle Disease Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Newcastle Disease Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Newcastle Disease Vaccine Market Size by Country
        9.3.1 Latin America Newcastle Disease Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Newcastle Disease Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Type
        10.1.1 Middle East and Africa Newcastle Disease Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Newcastle Disease Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Newcastle Disease Vaccine Market Size by Application
        10.2.1 Middle East and Africa Newcastle Disease Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Newcastle Disease Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Newcastle Disease Vaccine Market Size by Country
        10.3.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merial
        11.1.1 Merial Corporation Information
        11.1.2 Merial Overview
        11.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merial Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merial Recent Developments
    11.2 CEVA
        11.2.1 CEVA Corporation Information
        11.2.2 CEVA Overview
        11.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CEVA Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CEVA Recent Developments
    11.3 QYH Biotech
        11.3.1 QYH Biotech Corporation Information
        11.3.2 QYH Biotech Overview
        11.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 QYH Biotech Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 QYH Biotech Recent Developments
    11.4 Ringpu Biology
        11.4.1 Ringpu Biology Corporation Information
        11.4.2 Ringpu Biology Overview
        11.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Ringpu Biology Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Ringpu Biology Recent Developments
    11.5 Yebio
        11.5.1 Yebio Corporation Information
        11.5.2 Yebio Overview
        11.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Yebio Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Yebio Recent Developments
    11.6 Harbin Veterinary Research Institute
        11.6.1 Harbin Veterinary Research Institute Corporation Information
        11.6.2 Harbin Veterinary Research Institute Overview
        11.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Harbin Veterinary Research Institute Recent Developments
    11.7 Merck Animal Health
        11.7.1 Merck Animal Health Corporation Information
        11.7.2 Merck Animal Health Overview
        11.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Merck Animal Health Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck Animal Health Recent Developments
    11.8 DHN
        11.8.1 DHN Corporation Information
        11.8.2 DHN Overview
        11.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 DHN Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 DHN Recent Developments
    11.9 Zoetis
        11.9.1 Zoetis Corporation Information
        11.9.2 Zoetis Overview
        11.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Zoetis Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Zoetis Recent Developments
    11.10 ChengDu Tecbond
        11.10.1 ChengDu Tecbond Corporation Information
        11.10.2 ChengDu Tecbond Overview
        11.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 ChengDu Tecbond Recent Developments
    11.11 Elanco (Lohmann)
        11.11.1 Elanco (Lohmann) Corporation Information
        11.11.2 Elanco (Lohmann) Overview
        11.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Elanco (Lohmann) Recent Developments
    11.12 FATRO
        11.12.1 FATRO Corporation Information
        11.12.2 FATRO Overview
        11.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 FATRO Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 FATRO Recent Developments
    11.13 CAVAC
        11.13.1 CAVAC Corporation Information
        11.13.2 CAVAC Overview
        11.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 CAVAC Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 CAVAC Recent Developments
    11.14 Vaksindo
        11.14.1 Vaksindo Corporation Information
        11.14.2 Vaksindo Overview
        11.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Vaksindo Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Vaksindo Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Newcastle Disease Vaccine Industry Chain Analysis
    12.2 Newcastle Disease Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Newcastle Disease Vaccine Production Mode & Process
    12.4 Newcastle Disease Vaccine Sales and Marketing
        12.4.1 Newcastle Disease Vaccine Sales Channels
        12.4.2 Newcastle Disease Vaccine Distributors
    12.5 Newcastle Disease Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Newcastle Disease Vaccine Industry Trends
    13.2 Newcastle Disease Vaccine Market Drivers
    13.3 Newcastle Disease Vaccine Market Challenges
    13.4 Newcastle Disease Vaccine Market Restraints
14 Key Findings in The Global Newcastle Disease Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Live Vaccines
    Table 3. Major Manufacturers of Killed Vaccines
    Table 4. Global Newcastle Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Newcastle Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Newcastle Disease Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Newcastle Disease Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Newcastle Disease Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Newcastle Disease Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Newcastle Disease Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Newcastle Disease Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Newcastle Disease Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Newcastle Disease Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Newcastle Disease Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Newcastle Disease Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Newcastle Disease Vaccine Price by Manufacturers (2017-2022) &(USD/K Doses)
    Table 19. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2021)
    Table 21. Newcastle Disease Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Newcastle Disease Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Newcastle Disease Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Newcastle Disease Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Newcastle Disease Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Newcastle Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Newcastle Disease Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Newcastle Disease Vaccine Revenue Share by Type (2023-2028)
    Table 33. Newcastle Disease Vaccine Price by Type (2017-2022) & (USD/K Doses)
    Table 34. Global Newcastle Disease Vaccine Price Forecast by Type (2023-2028) & (USD/K Doses)
    Table 35. Global Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Newcastle Disease Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Newcastle Disease Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Newcastle Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Newcastle Disease Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Newcastle Disease Vaccine Revenue Share by Application (2023-2028)
    Table 43. Newcastle Disease Vaccine Price by Application (2017-2022) & (USD/K Doses)
    Table 44. Global Newcastle Disease Vaccine Price Forecast by Application (2023-2028) & (USD/K Doses)
    Table 45. North America Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Newcastle Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Newcastle Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Newcastle Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Newcastle Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Newcastle Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Newcastle Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Newcastle Disease Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Newcastle Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Newcastle Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Newcastle Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Newcastle Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merial Corporation Information
    Table 106. Merial Description and Major Businesses
    Table 107. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 108. Merial Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merial Recent Developments
    Table 110. CEVA Corporation Information
    Table 111. CEVA Description and Major Businesses
    Table 112. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 113. CEVA Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. CEVA Recent Developments
    Table 115. QYH Biotech Corporation Information
    Table 116. QYH Biotech Description and Major Businesses
    Table 117. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 118. QYH Biotech Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. QYH Biotech Recent Developments
    Table 120. Ringpu Biology Corporation Information
    Table 121. Ringpu Biology Description and Major Businesses
    Table 122. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 123. Ringpu Biology Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Ringpu Biology Recent Developments
    Table 125. Yebio Corporation Information
    Table 126. Yebio Description and Major Businesses
    Table 127. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 128. Yebio Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Yebio Recent Developments
    Table 130. Harbin Veterinary Research Institute Corporation Information
    Table 131. Harbin Veterinary Research Institute Description and Major Businesses
    Table 132. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 133. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Harbin Veterinary Research Institute Recent Developments
    Table 135. Merck Animal Health Corporation Information
    Table 136. Merck Animal Health Description and Major Businesses
    Table 137. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 138. Merck Animal Health Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Merck Animal Health Recent Developments
    Table 140. DHN Corporation Information
    Table 141. DHN Description and Major Businesses
    Table 142. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 143. DHN Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. DHN Recent Developments
    Table 145. Zoetis Corporation Information
    Table 146. Zoetis Description and Major Businesses
    Table 147. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 148. Zoetis Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Zoetis Recent Developments
    Table 150. ChengDu Tecbond Corporation Information
    Table 151. ChengDu Tecbond Description and Major Businesses
    Table 152. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 153. ChengDu Tecbond Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. ChengDu Tecbond Recent Developments
    Table 155. Elanco (Lohmann) Corporation Information
    Table 156. Elanco (Lohmann) Description and Major Businesses
    Table 157. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 158. Elanco (Lohmann) Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Elanco (Lohmann) Recent Developments
    Table 160. FATRO Corporation Information
    Table 161. FATRO Description and Major Businesses
    Table 162. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 163. FATRO Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. FATRO Recent Developments
    Table 165. CAVAC Corporation Information
    Table 166. CAVAC Description and Major Businesses
    Table 167. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 168. CAVAC Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. CAVAC Recent Developments
    Table 170. Vaksindo Corporation Information
    Table 171. Vaksindo Description and Major Businesses
    Table 172. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 173. Vaksindo Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Vaksindo Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Newcastle Disease Vaccine Distributors List
    Table 178. Newcastle Disease Vaccine Customers List
    Table 179. Newcastle Disease Vaccine Market Trends
    Table 180. Newcastle Disease Vaccine Market Drivers
    Table 181. Newcastle Disease Vaccine Market Challenges
    Table 182. Newcastle Disease Vaccine Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Newcastle Disease Vaccine Product Picture
    Figure 3. Global Newcastle Disease Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Live Vaccines Product Picture
    Figure 4. Killed Vaccines Product Picture
    Figure 5. Global Newcastle Disease Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Chicken
    Figure 7. Duck & Goose
    Figure 8. Other
    Figure 9. Newcastle Disease Vaccine Report Years Considered
    Figure 10. Global Newcastle Disease Vaccine Sales 2017-2028 (M Doses)
    Figure 11. Global Newcastle Disease Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Newcastle Disease Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Newcastle Disease Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Newcastle Disease Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Newcastle Disease Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Newcastle Disease Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 17. North America Newcastle Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Newcastle Disease Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 19. Europe Newcastle Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Newcastle Disease Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 21. Asia-Pacific Newcastle Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Newcastle Disease Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 23. Latin America Newcastle Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Newcastle Disease Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 25. Middle East & Africa Newcastle Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Newcastle Disease Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Newcastle Disease Vaccine in the World: Market Share by Newcastle Disease Vaccine Revenue in 2021
    Figure 28. Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Newcastle Disease Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Newcastle Disease Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Newcastle Disease Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Newcastle Disease Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Newcastle Disease Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Newcastle Disease Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Newcastle Disease Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Newcastle Disease Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Newcastle Disease Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Newcastle Disease Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Newcastle Disease Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Newcastle Disease Vaccine Value Chain
    Figure 87. Newcastle Disease Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Frequently Asked Questions
Newcastle Disease Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Newcastle Disease Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Newcastle Disease Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Radiopharmaceutical

Radiopharmaceutical market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

VOC's Rotor

VOC's Rotor market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More